Articles by tag "100-146"

1. OPEN ACCESS: Ramachandran, Anassuya et al. (2021) Pathogenic ACVR1(R206H) activation by Activin A‐induced receptor clustering and autophosphorylation. EMBO J.
2. OPEN ACCESS: Pandey, Kirti et al. (2023) A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. Front Oncol.
3. Dual-enzyme activated theranostic nanoparticles for image-guided glioblastoma therapy
4. Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
5. High-Throughput Screening on Primary Tumor-Associated Microglia and Macrophages Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Partners for Immunotherapy in Glioblastoma
6. Differential Phagocytosis induces Diverse Macrophage Activation States in Malignant Gliomas
7. The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases
8. Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma
9. Reduced EZH1/2 expression in imipridone-treated cells correlates with synergy following combinations with EZH1/2 or HDAC inhibitors in diffuse glioma and other tumors
10. Multi-omics landscape of alternative splicing in diffuse midline glioma reveals immune- and neural-driven subtypes with implications for spliceosome-targeted therapy